America First Investment Advisors, LLC Abbott Laboratories Transaction History

America First Investment Advisors, LLC

$368 Million
Q2 2024

A detailed history of America First Investment Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, America First Investment Advisors, LLC holds 183,631 shares of ABT stock, worth $20.7 Million. This represents 5.19% of its overall portfolio holdings.

Number of Shares

183,631

Previous 171,959 6.79%

Holding current value

$20.7 Million

Previous $19.5 Million 2.37%

% of portfolio

5.19%

Previous 5.25%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$100.73 - $112.44 $1.18 Million - $1.31 Million	11,672 Added 6.79%	183,631 $19.1 Million
Q1 2024 Apr 22, 2024	BUY	$109.52 - $120.96 $57,717 - $63,745	527 Added 0.31%	171,959 $19.5 Million
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $334,514 - $409,473	3,709 Added 2.21%	171,432 $18.9 Million
Q3 2023 Nov 03, 2023	BUY	$95.53 - $114.62 $121,418 - $145,682	1,271 Added 0.76%	167,723 $16.2 Million
Q2 2023 Aug 02, 2023	BUY	$100.78 - $112.29 $98,865 - $110,156	981 Added 0.59%	166,452 $18.1 Million
Q1 2023 May 03, 2023	BUY	$96.86 - $114.01 $260,940 - $307,142	2,694 Added 1.66%	165,471 $16.8 Million
Q4 2022 Jan 31, 2023	BUY	$95.06 - $111.52 $489,559 - $574,328	5,150 Added 3.27%	162,777 $17.9 Million
Q3 2022 Nov 03, 2022	BUY	$96.76 - $112.03 $1.13 Million - $1.31 Million	11,678 Added 8.0%	157,627 $15.3 Million
Q2 2022 Jul 12, 2022	BUY	$102.07 - $123.37 $76,144 - $92,034	746 Added 0.51%	145,949 $15.9 Million
Q1 2022 Apr 26, 2022	SELL	$114.02 - $139.04 $34,548 - $42,129	-303 Reduced 0.21%	145,203 $17.2 Million
Q4 2021 Jan 20, 2022	BUY	$115.53 - $141.46 $150,997 - $184,888	1,307 Added 0.91%	145,506 $20.5 Million
Q3 2021 Nov 02, 2021	SELL	$116.66 - $129.06 $225,387 - $249,343	-1,932 Reduced 1.32%	144,199 $17 Million
Q2 2021 Jul 27, 2021	BUY	$105.79 - $124.53 $797,868 - $939,205	7,542 Added 5.44%	146,131 $16.9 Million
Q1 2021 Apr 28, 2021	SELL	$108.84 - $128.23 $528,962 - $623,197	-4,860 Reduced 3.39%	138,589 $16.6 Million
Q4 2020 Feb 01, 2021	SELL	$105.0 - $114.42 $695,520 - $757,918	-6,624 Reduced 4.41%	143,449 $15.7 Million
Q3 2020 Oct 15, 2020	SELL	$91.64 - $111.29 $4.99 Million - $6.06 Million	-54,472 Reduced 26.63%	150,073 $16.3 Million
Q2 2020 Jul 16, 2020	SELL	$76.57 - $98.0 $150,766 - $192,962	-1,969 Reduced 0.95%	204,545 $18.7 Million
Q1 2020 Apr 29, 2020	SELL	$62.82 - $91.86 $499,607 - $730,562	-7,953 Reduced 3.71%	206,514 $16.3 Million
Q4 2019 Feb 05, 2020	SELL	$78.51 - $87.4 $513,533 - $571,683	-6,541 Reduced 2.96%	214,467 $18.6 Million
Q3 2019 Nov 04, 2019	SELL	$81.84 - $88.74 $70,055 - $75,961	-856 Reduced 0.39%	221,008 $18.5 Million
Q2 2019 Jul 29, 2019	SELL	$72.88 - $85.0 $354,561 - $413,525	-4,865 Reduced 2.15%	221,864 $18.7 Million
Q1 2019 Apr 22, 2019	SELL	$66.22 - $80.06 $630,679 - $762,491	-9,524 Reduced 4.03%	226,729 $18.1 Million
Q4 2018 Jan 16, 2019	SELL	$65.56 - $74.27 $841,659 - $953,478	-12,838 Reduced 5.15%	236,253 $17.1 Million
Q3 2018 Oct 15, 2018	SELL	$60.81 - $73.36 $340,536 - $410,816	-5,600 Reduced 2.2%	249,091 $18.3 Million
Q2 2018 Jul 20, 2018	SELL	$57.57 - $63.54 $48,819 - $53,881	-848 Reduced 0.33%	254,691 $15.5 Million
Q1 2018 Apr 20, 2018	SELL	$56.27 - $63.62 $5,401 - $6,107	-96 Reduced 0.04%	255,539 $15.3 Million
Q4 2017 Feb 12, 2018	SELL	$53.68 - $57.47 $28,020 - $29,999	-522 Reduced 0.2%	255,635 $14.6 Million
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $12.3 Million - $13.7 Million	256,157	256,157 $13.7 Million

Others Institutions Holding ABT

# of Institutions

3,138

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of America First Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on America First Investment Advisors, LLC with notifications on news.

Account

America First Investment Advisors, LLC Abbott Laboratories Transaction History